Location:
The Kirby Institute Level 6 Seminar Room Wallace Wurth Building UNSW Australia Sydney NSW 2052
Open to
All
Contact for enquiries
Rata Joseph +61 (0)2 9385 0900 rjoseph@kirby.unsw.edu.au
The Kirby Institute is pleased to present:
Abstract:
The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI is a global model of collaborative science and the premier international venue for bridging basic and clinical investigation to clinical practice in the field of HIV and related viruses. CROI 2016was held from February 22 to February 25, 2016, in Boston, Massachusettshttp://www.croiconference.org/. The seminar will provide feedback from CROI on key themes including HIV cure, treatment and HCV coinfection.
Bio:
| Prof Sean Emery is Head of Therapeutic and Vaccine Research Program (TVRP), The Kirby Institute UNSW Australia and Deputy Dean (Research) Faculty of Medicine, UNSW Australia |
|
|
| Dr Martinello completed advanced training in infectious diseases in 2014, following which she commenced her PhD at the Kirby Institute. She also works at St Vincent’s Hospital as the Viral Hepatitis Research Fellow. |  |
|
| Dr Koelsch is a Senior Lecturer in Medicine and Specialist Physician (Internal Medicine) who has worked in Germany, the United States of America and Australia. His clinical focus is in Immunology and Infectious Diseases with a special interest in HIV medicine. In addition to his medical training and board certification in Medicine, he completed a doctorate by research in molecular biology at the Faculty of Medicine at the University of Hamburg, Germany. In 2001 he joined Prof. Douglas Richman's HIV research laboratory at the Centre for AIDS Research at the University of California, San Diego, USA. In 2008 Dr Koelsch was appointed to the University of New South Wales, Sydney at the Kirby Institute (formerly the National Centre in HIV Epidemiology and Clinical Research) and St Vincent's Hospital, Centre for Applied Medical Research. He has since lead a translational research group within the Immunovirology Program of the Kirby Institute with a primary focus on the pathogenesis of HIV persistence. He is also conducting clinical studies at St Vincent's Hospital, Sydney that are aimed at developing a cure for HIV infection. |  |
